Solid Tumor: Clinical Trials

41 trials for Solid Tumor, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

16 unknown, 14 recruiting, 4 completed, 3 terminated. 41 Early Phase 1.

By phase and status

PhaseTrialsStatus
Early Phase 141Unknown 16, Recruiting 14, Completed 4, Terminated 3, Not yet recruiting 2, Active not recruiting 1, Withdrawn 1

Follow Solid Tumor: new trials by email Literature Review of Solid Tumor trials Research Report on Solid Tumor

Trials (filtered) newest first · largest first

All 41 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
An Exploratory Study of Personalized Cancer Vaccine in Adjuvant Therapy of Solid Tumors
ABO2109 Injection, Toripalimab - Solid Tumor
Early Phase 1RecruitingRuijin Hospital602026-06-092026-08-03
Functionally Enhanced ALPP-Targeted Engineered T Cells in Advanced Solid Tumors
Enhanced ALPP CAR-T treatment - Solid Tumor
Early Phase 1RecruitingTCRCure Biopharma Ltd.242026-02-282026-03-23
TCR-T Cell Therapy for KRAS Mutation in Advanced Solid Tumors
TCR-T cells, Fludarabine, Cyclophosphamide - KRAS G12V, KRAS G12D
Early Phase 1Not yet recruitingSun Yat-sen University252026-02-012026-01-15
This is a Multi-Center Study of IBI3026 in Participants With Locally Advanced, Unresectable or Metastatic Solid Tumors
IBI3026 - Solid Tumor
Early Phase 1RecruitingInnovent Biologics Technology Limited (Shanghai R&D Center)3002026-01-292026-02-04
Engineered T-cell Therapy for Patients With ALPP-Positive Advanced Solid Tumors
Anti ALPP CAR-T cells treatment - Solid Tumor
Early Phase 1TerminatedTCRCure Biopharma Ltd.52025-05-202026-01-22
PET-imaging of Two Vartumabs in Patients With Solid Tumors
89Zr-DFO-N-Suc-F8scFv, 89Zr-DFO-N-Suc-C9scFv, PET/CT scan - Solid Tumor, Colon Carcinoma
Early Phase 1RecruitingVar2 Pharmaceuticals322024-12-102025-12-29
An Investigator-initiated Clinical Study of LM303 Injection for the Treatment of Advanced Solid Tumours
LM303 - Solid Tumor
Early Phase 1RecruitingSuzhou BlueHorse Therapeutics Co., Ltd.102024-10-172024-11-19
HS-IT201 Injection in the Treatment of Advanced Solid Tumors
HS-IT201 Injection - Solid Tumor
Early Phase 1Not yet recruitingHangzhou Huasai Biomedicine Co., Ltd.92024-10-012024-09-25
Genetically Modified T Cells Treating Malignant Tumors
CAR-T cell reinfusion - Solid Tumor
Early Phase 1RecruitingYi Zhang1002024-08-182024-09-25
An Exploratory Study by Fast CAR T Cells
Fast CAR T cells - Solid Tumor
Early Phase 1RecruitingShanghai Cell Therapy Group Co.,Ltd202024-03-072024-03-25
Indocyanine Green (ICG) Guided Sentinel Lymph Node Mapping for Pediatric Visceral Solid Tumors
Indocyanine Green - Solid Tumor
Early Phase 1RecruitingSt. Jude Children's Research Hospital352023-10-242026-10-30
A Clinical Study on LM103 Injection for the Treatment of Advanced Solid Tumors
LM103 - Solid Tumor
Early Phase 1UnknownSuzhou BlueHorse Therapeutics Co., Ltd.52023-08-012023-08-02
A Clinical Study on TILs for the Treatment of Advanced Solid Tumors
LM103 - Solid Tumor
Early Phase 1UnknownSuzhou BlueHorse Therapeutics Co., Ltd.202023-08-012023-08-02
An Exploratory Study on the Treatment of Advanced Solid Tumors by Fast CAR T Cells
Fast CAR T cells - Solid Tumor
Early Phase 1RecruitingShanghai Cell Therapy Group Co.,Ltd122023-06-012024-02-08
Safety and Efficacy of an Autologous Tumor Infiltrating Lymphocyte (TIL) Therapy in Patients with Advanced Solid Tumors
BEN101 - Solid Tumor
Early Phase 1RecruitingShanghai General Hospital, Shanghai Jiao Tong University School of Medicine162023-05-232024-09-19
A Clinical Study on LM103 for the Treatment of Advanced Solid Tumors
LM103 - Solid Tumor
Early Phase 1UnknownSuzhou BlueHorse Therapeutics Co., Ltd.52023-05-192023-07-12
Autologous Tumor Infiltrating Lymphocyte Injection for the Treatment of Advanced Solid Tumors
GT316 - Solid Tumor, Adult
Early Phase 1TerminatedGrit Biotechnology22023-02-262026-04-29
Exploratory Clinical Study of Autologous Tumor-infiltrating Lymphocyte Injection (GT201) for Advanced Gynecologic Tumors
GT201 - Solid Tumor
Early Phase 1UnknownRenJi Hospital242023-02-012023-02-13
Safety, Tolerability and Preliminary Efficacy of Engineered Red Blood Cell in Patients With Advanced Malignancies
engineered red blood cell - Cancer, Solid Tumor
Early Phase 1UnknownWestlake Therapeutics302023-01-162024-07-24
Exploratory Study of MSLN-CAR T Cells Secreting PD1/CTLA-4 Nanoantibody for the Treatment of Advanced Solid Tumors
αPD1/CTLA4-MSLN-CAR T cells - Solid Tumor
Early Phase 1RecruitingShanghai Cell Therapy Group Co.,Ltd162023-01-012024-02-08

Showing 20 of 41. Sign in to see all of them.

Narrower conditions

Neoplasms (3)  ·  Breast Neoplasms (2)  ·  Pancreatic Neoplasms (2)  ·  Sarcoma (2)  ·  Squamous Cell Carcinoma of Head and Neck (2)  ·  Stomach Neoplasms (2)  ·  Chondrosarcoma (1)  ·  Colonic Neoplasms (1)  ·  Esophageal Neoplasms (1)  ·  Glioblastoma (1)  ·  Head and Neck Neoplasms (1)  ·  Hematologic Neoplasms (1)  ·  Lung Neoplasms (1)  ·  Lymphoma (1)  ·  Melanoma (1)

Broader conditions

Neoplasms by Site (5)  ·  Neoplasms (4)  ·  Neoplasms by Histologic Type (3)  ·  Neoplasms, Germ Cell and Embryonal (3)  ·  Neoplasms, Glandular and Epithelial (3)  ·  Neoplasms, Nerve Tissue (3)  ·  Neuroectodermal Tumors (3)  ·  Skin Diseases (3)  ·  Skin and Connective Tissue Diseases (3)  ·  Breast Diseases (2)  ·  Carcinoma (2)  ·  Carcinoma, Squamous Cell (2)  ·  Digestive System Diseases (2)  ·  Digestive System Neoplasms (2)  ·  Endocrine Gland Neoplasms (2)

Interventions

Cyclophosphamide (3)  ·  fludarabine (3)  ·  alpha-Synuclein (2)  ·  Alemtuzumab (1)  ·  Aspirin (1)  ·  Bevacizumab (1)  ·  Carboxylesterase (1)  ·  Cyclosporine (1)  ·  Cyclosporins (1)  ·  Etoposide (1)  ·  Fibroblast Growth Factor 7 (1)  ·  Fluorodeoxyglucose F18 (1)  ·  Indocyanine Green (1)  ·  Interleukin-2 (1)  ·  KD025 (1)

Sponsors

Suzhou BlueHorse Therapeutics Co., Ltd. (4)  ·  Shanghai Cell Therapy Group Co.,Ltd (3)  ·  Allife Medical Science and Technology Co., Ltd. (2)  ·  SmartNuclide Biopharma (2)  ·  TCRCure Biopharma Ltd. (2)  ·  jianming xu (2)  ·  Affiliated Hospital of Jiangnan University (1)  ·  Case Comprehensive Cancer Center (1)  ·  Fujian Cancer Hospital (1)  ·  Grit Biotechnology (1)  ·  Hangzhou Huasai Biomedicine Co., Ltd. (1)  ·  Innovent Biologics Technology Limited (Shanghai R&D Center) (1)  ·  Miller Children's & Women's Hospital Long Beach (1)  ·  Montefiore Medical Center (1)  ·  Peking University (1)

Countries

China (23)  ·  United States (7)  ·  Netherlands (1)  ·  South Korea (1)

Top investigators

Jinxing Lou (3)  ·  Liyan Miao, Ph.D (2)  ·  Songbing Qin (2)  ·  Tangfeng Lv, MD (2)  ·  Alok A Khorana, MD (1)  ·  Andrew Davidoff, MD (1)  ·  Baiyong Shen (1)  ·  Chunjing Yu (1)  ·  Gooitzen van Dam, MD, PhD (1)  ·  Hongxia Wang, Doctor (1)  ·  Howard Lee, MD, PhD (1)  ·  Kris M Mahadeo, MD,MPH (1)  ·  Laura Klesse, MD, PhD (1)  ·  Leslie Fecher (1)  ·  Lin Shen, Prof. Dr. (1)

Results publications

PMID 42109657, PMID 35829748, PMID 36923556, PMID 39653817